Home>CELL THERAPY>Holoderm


[Prescription drug] [Workers’ Compensation reimbursement]


Holoderm® ​​is Korea's first and world's second commercialized cultured skin autograft. 


A very small (1~3cm2) skin biopsy is taken from the patient with severe degree burn, and the stem cells therefrom are cultured into sheet grafts, which are then transplanted on the patient's wound. Production takes 2-3 weeks, during which enough grafts can be obtained to cover the entire adult body surface. It is the most effective life-saver for the patient who has lost over 50% of her/his skin.


Holoderm® ​​has saved over 800 lives since 2002 and its usage is fully reimbursed by Korea's Workers' Compensation scheme.


Transplanted on the wound to generate a functional epidermal layer as follows:


1.Deep 2nd degree burn over 30% of TBSA


2.3rd degree burn over 10% of TBSA

Active Ingredient

 Autologous Keratinocytes